Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.285
+0.025 (1.11%)
Aug 19, 2026, 10:02 AM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $98.14 million as of August 19, 2026. Its market cap has increased by 50.53% in one year.
Market Cap
98.14M
Enterprise Value
98.50M
1-Year Change
50.53%
Ranking
Category
Stock Price
$2.29
ChartMarket Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $98.14M, a decrease of -92.64%. That is a compound annual growth rate of -35.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 98.14M | 7.66% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaxCyte | 136.23M |
| Apyx Medical | 127.64M |
| Quanterix | 122.49M |
| Microbot Medical | 104.11M |
| LENSAR | 100.71M |
| Hyperfine | 94.69M |
| electroCore | 89.89M |
| Outset Medical | 84.78M |